1.Immunodynamic changes in a mouse model of malignant pleural effusion
Xiao-Lei WEI ; Xu GUO ; Chuang-Xin ZHANG ; Qi WANG ; Xiao-Fan LIU ; Ming-Ming SHAO ; Huan-Zhong SHI ; Kan ZHAI
Laboratory Animal Research 2026;42(1):59-67
Background:
Malignant pleural effusion (MPE), a common complication of advanced cancers, is associated with poor prognosis and reduced quality of life. Although host–tumor interactions are known to drive MPE development, the associated immune dynamics during disease progression remain unclear. Using a Lewis lung carcinoma-induced MPE model in C57BL/6JNidfc mice, we systematically evaluated general parameters and immune cell changes at two-day intervals throughout disease progression.
Results:
The day of Lewis lung carcinoma cell injection into the pleural space was designated as day 0. By day 10 post-injection (p.i.), MPE-bearing mice exhibited ~ 10% body weight loss, marking the experimental endpoint. Pleural tumor mass and pleural effusion volume were minimal up to day 4 p.i. but increased sharply from day 6 onward.CD45⁺ immune cell counts rose over time, and days 6, 8, and 10 p.i. marked key stages of MPE progression. On day 6, B cells, T cells, and natural killer cells, but not macrophages and neutrophils, increased significantly compared to earlier timepoints. By day 8, all immune cell subsets except T cells exceeded day 6 levels, and at day 10, natural killer cell numbers declined while others continued to increase. Besides, the numbers of CD8⁺ T cells, Th1 cells, regulatory T cells, and M2 macrophages progressively increased from day 6 to 10. Based on these data, days 6 and 10 were defined as early and advanced MPE stages, respectively, with distinct immune phenotypes. In advanced MPE, CD8⁺ T cells displayed reduced IFN-γ, TNF-α, Granzyme B, Perforin, FasL, and Ki-67, but upregulated PD-1 and CTLA-4 relative to early stage. Similarly, Th1 cells showed decreased IFN-γ, TNF-α, and IL-2 production along with reduced Ki-67 expression. Advanced-stage M2 macrophages exhibited lower MHC-II levels and impaired phagocytosis, but higher PD-L1 and IL-10 production, while neutrophils showed reduced TNF-α release and phagocytic activity.
Conclusions
Our findings characterize the temporal immune dynamics associated with MPE progression in a mouse model, revealing a transition from an early immunostimulatory state to a late immunosuppressive state. This study enhances our understanding of MPE immunopathogenesis and provides a foundation for developing precise, stagespecific therapeutic strategies.
2.Material basis and mechanism of action of Arisaematis Rhizoma Preparatum in treatment of chronic obstructive pulmonary disease based on animal experiments, UPLC Q-Exactive Orbitrap MS, and network pharmacology.
Lin CHU ; Shao-Qing ZHU ; Zi-Xuan YANG ; Wei WANG ; Huan YANG
China Journal of Chinese Materia Medica 2025;50(7):1792-1802
This study investigates the material basis and mechanism of Arisaematis Rhizoma Preparatum in the treatment of chronic obstructive pulmonary disease(COPD) using animal experiments, component analysis, network pharmacology, and molecular docking. A mouse model of COPD was constructed by cigarette smoke and lipopolysaccharide(LPS). Blood gas analysis was performed to measure the pH and partial pressure of carbon dioxide(PCO_2) in the blood of the mice. Lung tissue sections were analyzed using HE staining, and the effects of Arisaematis Rhizoma Preparatum water extract on inflammatory factors(TNF-α, IL-6, and IL-1β) and the PI3K/AKT signaling pathway in the lung tissue of COPD model mice were studied by qPCR and Western blot. The composition of the Arisaematis Rhizoma Preparatum water extract was analyzed using UPLC Q-Exactive Orbitrap MS. The SwissTargetPrediction database was used to predict the targets of the chemical components in Arisaematis Rhizoma Preparatum. GeneCards, OMIM, TTD, PharmGKB and DrugBank disease databases were used to screen for COPD targets, and the potential targets of Arisaematis Rhizoma Preparatum in treating COPD were identified. A protein-protein interaction(PPI) network of intersection targets was constructed and analyzed using the STRING database and Cytoscape 3.9.0, and core genes were screened. GO functional analysis and KEGG pathway enrichment analysis were performed using R language, and molecular docking verification was conducted using AutoDock Vina software. The results of the animal experiments showed that Arisaematis Rhizoma Preparatum water extract improved pulmonary ventilation function in COPD model mice, reduced lung inflammatory cells, decreased alveolar cavities, and improved lung tissue condition. The levels of inflammatory factors TNF-α, IL-6 and IL-1β were decreased, and the phosphorylation levels of PI3K and AKT were inhibited. Fifty-two chemical components were identified from Arisaematis Rhizoma Preparatum, and 440 intersection targets related to COPD were found. Nine key components were screened, including hydroxyphenylethylamine, L-tyrosine, L-tyrosyl-L-alanine, 3,4,5-trihydroxy-1-cyclohexene-1-carboxylic acid, methyl azelate, zingerone, 6-gingerol, linoleamide, and linoleoyl ethanolamine. Five core targets were identified, including AKT1, TNF, STAT3, ESR1, and IL1B. The PI3K/AKT pathway was identified as the key pathway for the treatment of COPD with Arisaematis Rhizoma Preparatum. Molecular docking results showed that 75% of the binding energies of key components and core targets were less than-5 kcal·mol~(-1), indicating good binding affinity. In conclusion, Arisaematis Rhizoma Preparatum may improve pulmonary ventilation function, enhance lung pathological morphology, and reduce pulmonary inflammation in COPD model mice by inhibiting the PI3K/AKT signaling pathway and downregulating TNF-α, IL-6, and IL-1β inflammatory factors. The material basis may be associated with L-tyrosyl-L-alanine, 3,4,5-trihydroxy-1-cyclohexene-1-carboxylic acid, zingerone and 6-gingerol, and AKT1 and TNF may be the primary targets.
Animals
;
Pulmonary Disease, Chronic Obstructive/metabolism*
;
Network Pharmacology
;
Mice
;
Drugs, Chinese Herbal/administration & dosage*
;
Male
;
Rhizome/chemistry*
;
Humans
;
Molecular Docking Simulation
;
Chromatography, High Pressure Liquid
;
Disease Models, Animal
;
Signal Transduction/drug effects*
;
Lung/metabolism*
;
Phosphatidylinositol 3-Kinases/metabolism*
;
Tumor Necrosis Factor-alpha/metabolism*
;
Proto-Oncogene Proteins c-akt/metabolism*
;
Interleukin-6/immunology*
3.Epidemiological characteristics and spatiotemporal clustering analysis of varicella in Lu'an City in 2005 - 2023
Huan ZHANG ; Bingxin MA ; Yafei CHEN ; Yao WANG ; Fan PAN ; Lei ZHANG ; Kai CHENG ; Ling SHAO ; Wei QIN
Journal of Public Health and Preventive Medicine 2025;36(6):58-61
Objective To analyze the epidemiological characteristics and spatiotemporal clustering of varicella in Lu'an City from 2005 to 2023, and to provide a scientific basis for optimizing varicella prevention and control strategies. Methods Data on varicella cases were collected through the Chinese Center for Disease Control and Prevention Information System. Descriptive epidemiology, temporal trend analysis, seasonal analysis, spatiotemporal clustering analysis, and spatial autocorrelation analysis were conducted using QGIS, JoinPoint, SaTScan and GeoDa software. Results The average annual reported incidence rate of varicella in Lu'an City from 2005 to 2023 was 34.55/100,000, showing a trend of initial increase followed by a decrease. The peak incidence occurred from October to January of the following year (RR=1.97, LLR=1743.95, P=0.001). Students aged 0 to 19 was the primary affected group. Spatiotemporal scan analysis revealed four types of spatiotemporal clusters, with the cluster in Jin'an District from October 2017 to December 2023 being particularly prominent (RR=2.87,LLR=1734.15,P<0.001). Spatial autocorrelation analysis indicated significant clustering of varicella cases in the main urban area (Moran's I=0.216,Z=4.786,P=0.003). Conclusion The incidence of varicella in Lu'an City exhibits distinct seasonal and spatial clustering, and schools and kindergartens in the main urban area are the key to varicella prevention and control. It is necessary to enhance the monitoring of disease outbreaks during peak periods and in key areas, and to increase the two-dose vaccination rate for varicella in areas with case aggregation and among key populations.
4.Chemical constituents from Pyrolae Herba and their inhibitory activity against pathogenic bacteria associated with sports injuries
Ya-li LIU ; Shao-wen LIU ; Yu WANG ; Yi ZHANG ; Ji-hong WANG ; Xiao-huan ZHOU ; Su-li MA
Chinese Traditional Patent Medicine 2025;47(5):1524-1530
AIM To study the chemical constituents from Pyrolae Herba and their activity against pathogenic bacteria associated with sports injuries.METHODS Silica gel and Sephadex LH-20 were used for isolation and purification,then the structures of obtained compounds were identified by physicochemical properties and spectral data.The antibacterial activity was detected by filter paper method.RESULTS Twenty five compounds were isolated and identified as manuleoside H(1),5-hydroxy-3,7-dimethoxy-4,-methyl flavone(2),5-hydroxy-3,7,4'-methoxy-flavone(3),5-hydroxy-7,3',4'-trimethoxy-flavone(4),5,7-dihydroxy-3-methoxy-flavone(5),7.5,4'-trihydroxyflavone(6),ethyl vanillate(7),clovandiol(8),hydroxydihydrobovolide(9),zanthopyranone(10),eugenin(11),berchemol(12),3,7-dimethoxy-5,3',4'-trihydroxyflavone(13),2,5-dimethyl-7-hydroxychromone(14),rutalinium(15),formononetin(16),8-hydroxy-4',7-dimethoxy-isoflavones(17),isoline(18),dearabinosyl pneumonanthoside(19),3,5-dihydroxycinnamic acid(20),2,4,6-trihydroxyacetophenone(21),p-isopropyl benzoic acid(22),geraldone(23),ethylsyringin(24),4-hydroxyphenylethyl-2'-hydroxypropionate(25).Compounds 8,10,12,16 and 24 showed bacteriostatic zone on pathogenic bacteria susceptible to sports injuries.CONCLUSION All the compounds are isolated from Pyrolae Herba for the first time.Compounds 8,10,12,16 and 24 have inhibitory activity against pathogenic bacteria susceptible to sports injuries.
5.Prevention,control monitoring of environmental carbapenem-resistant Klebsiella pneumoniae in intensive care unit of a three-A hospital
Yuan LI ; Guangnan SHAO ; Keju GU ; Liang TIAN ; Chunyan LI ; Yun LIU ; Huan TANG ; Fei WANG ; Wei JI
Chinese Journal of Nosocomiology 2025;35(9):1391-1395
OBJECTIVE To carry out regular monitoring of carbapenem-resistant Klebsiella pneumoniae(CRKP)contamination status in the environment of intensive care unit(ICU)and take targeted prevention and control measures so as to reduce the incidence of hospital-associated infections with multidrug-resistant organisms(MDROs).METHODS The surfaces of surroundings of the patients who were colonized and infected with CRKP in the ICU of grade A tertiary hospital of Shanghai and the hands of relevant staff were sampled by stages from Jan 1,2021 to Jun 30,2024.The distribution of the CRKP strains in the surroundings were analyzed according to the locations positive for CRKP,and the disinfection measures were accordingly and continuously modified.The trend of isolation rate of CRKP strains from the ICU patients was analyzed during the time period when the measures were implemented.RESULTS Totally 266 environmental samples were collected during the baseline period(from Jan.1 2021 to Dec.31 2021),265 during intervention period(from Jan.1 2022 to Dec.31 2023),274 during con-solidation period(from Jan.1 to Jun.30 2024);the isolation rates of the CRKP strains were 4.51%,4.91%and 3.65%,respectively.The isolation rate of the strains was highest from the bed unit(10.40%),followed by the article for public use(6.74%),articles used by health care workers(2.98%)and diagnosis and treatment arti-cles(1.91%).The isolation rate of CRKP of the patients was 24.75%during the baseline period,15.48%during the intervention period,5.69%during the consolidation period,showing a continuously downward trend(x2=30.330,P<0.001).CONCLUSION It is necessary to regularly carry out the environmental monitoring of CRKP strains,seek for the weak links of environmental disinfection and implement the intensified prevention and control measures so as to reduce the incidence of CRKP infection,which may provide theoretical bases for effective control of the CRKP strains.
6.Analysis of risk factors and countermeasures for prolonged hospital stay in children with bronchopneumonia
Huan WANG ; Yan SHAO ; Ya WU ; Qiao XU
China Modern Doctor 2025;63(16):39-42
Objective To explore the risk factors and intervention countermeasures for prolonged hospital stay in children with bronchopneumonia.Methods A retrospective analysis was conducted on the clinical data of 152 children with bronchopneumonia admitted to Zhoushan Women and Children Hospital from April 2022 to June 2024.The children were divided into prolonged group(hospital stay ≥ 10 days,53 cases)and non-prolonged group(hospital stay<10d,99 cases)based on whether their hospital stay was prolonged.Multivariate Logistic regression analysis was used to determine the independent risk factors for prolonged hospital stay in children with bronchopneumonia.Pearson correlation analysis was used to determine the correlation between independent risk factors and prolonged hospital stay of the children.Results Univariate analysis showed that age,disease severity,duration of fever after admission,duration from onset to hospitalization,mycoplasma antibody,sputum culture,pneumonia and other related vaccination,and basic diseases were all influencing factors for prolonged hospital stay in children with bronchopneumonia(P<0.05).Multivariate Logistic regression analysis showed that age,disease severity,and duration of fever after admission were all independent influencing factors for prolonged hospital stay in children with bronchopneumonia(P<0.05).Age was negatively correlated with the prolongation of hospital stay(r=-0.285,P<0.001).The disease severity and duration of fever after admission were positively correlated with the prolongation of hospital stay(r=0.312,0.458,P<0.001).Conclusion Young age,severe condition and long duration of fever after admission are all independent risk factors for prolonged hospital stay in children with bronchopneumonia.
7.Prevention,control monitoring of environmental carbapenem-resistant Klebsiella pneumoniae in intensive care unit of a three-A hospital
Yuan LI ; Guangnan SHAO ; Keju GU ; Liang TIAN ; Chunyan LI ; Yun LIU ; Huan TANG ; Fei WANG ; Wei JI
Chinese Journal of Nosocomiology 2025;35(9):1391-1395
OBJECTIVE To carry out regular monitoring of carbapenem-resistant Klebsiella pneumoniae(CRKP)contamination status in the environment of intensive care unit(ICU)and take targeted prevention and control measures so as to reduce the incidence of hospital-associated infections with multidrug-resistant organisms(MDROs).METHODS The surfaces of surroundings of the patients who were colonized and infected with CRKP in the ICU of grade A tertiary hospital of Shanghai and the hands of relevant staff were sampled by stages from Jan 1,2021 to Jun 30,2024.The distribution of the CRKP strains in the surroundings were analyzed according to the locations positive for CRKP,and the disinfection measures were accordingly and continuously modified.The trend of isolation rate of CRKP strains from the ICU patients was analyzed during the time period when the measures were implemented.RESULTS Totally 266 environmental samples were collected during the baseline period(from Jan.1 2021 to Dec.31 2021),265 during intervention period(from Jan.1 2022 to Dec.31 2023),274 during con-solidation period(from Jan.1 to Jun.30 2024);the isolation rates of the CRKP strains were 4.51%,4.91%and 3.65%,respectively.The isolation rate of the strains was highest from the bed unit(10.40%),followed by the article for public use(6.74%),articles used by health care workers(2.98%)and diagnosis and treatment arti-cles(1.91%).The isolation rate of CRKP of the patients was 24.75%during the baseline period,15.48%during the intervention period,5.69%during the consolidation period,showing a continuously downward trend(x2=30.330,P<0.001).CONCLUSION It is necessary to regularly carry out the environmental monitoring of CRKP strains,seek for the weak links of environmental disinfection and implement the intensified prevention and control measures so as to reduce the incidence of CRKP infection,which may provide theoretical bases for effective control of the CRKP strains.
8.Analysis of risk factors and countermeasures for prolonged hospital stay in children with bronchopneumonia
Huan WANG ; Yan SHAO ; Ya WU ; Qiao XU
China Modern Doctor 2025;63(16):39-42
Objective To explore the risk factors and intervention countermeasures for prolonged hospital stay in children with bronchopneumonia.Methods A retrospective analysis was conducted on the clinical data of 152 children with bronchopneumonia admitted to Zhoushan Women and Children Hospital from April 2022 to June 2024.The children were divided into prolonged group(hospital stay ≥ 10 days,53 cases)and non-prolonged group(hospital stay<10d,99 cases)based on whether their hospital stay was prolonged.Multivariate Logistic regression analysis was used to determine the independent risk factors for prolonged hospital stay in children with bronchopneumonia.Pearson correlation analysis was used to determine the correlation between independent risk factors and prolonged hospital stay of the children.Results Univariate analysis showed that age,disease severity,duration of fever after admission,duration from onset to hospitalization,mycoplasma antibody,sputum culture,pneumonia and other related vaccination,and basic diseases were all influencing factors for prolonged hospital stay in children with bronchopneumonia(P<0.05).Multivariate Logistic regression analysis showed that age,disease severity,and duration of fever after admission were all independent influencing factors for prolonged hospital stay in children with bronchopneumonia(P<0.05).Age was negatively correlated with the prolongation of hospital stay(r=-0.285,P<0.001).The disease severity and duration of fever after admission were positively correlated with the prolongation of hospital stay(r=0.312,0.458,P<0.001).Conclusion Young age,severe condition and long duration of fever after admission are all independent risk factors for prolonged hospital stay in children with bronchopneumonia.
9.Discussion on the Wenzi Jiedu Method for Treating Malignant Tumors Based on the Theory of Circulation of Phase Fire
Yutian GU ; Hongguang ZHOU ; Hao LI ; Xinyan DAI ; Yan SHAO ; Huan YANG ; Weichen YUAN
Journal of Nanjing University of Traditional Chinese Medicine 2025;41(5):567-575
Based on the theory of circulation of qi,a theoretical model of the circulation of phase fire in the human body was con-structed.It is proposed that cancer toxicity is the key factor that triggers the disorder of phase fire and hinders the circulation of phase fire.The disorder of phase fire and poor circulation are important pathogenesis of the occurrence and development of cancer toxicity.With the principle of strengthening healthy qi and eliminating evil qi,the Wenzi Jiedu method is used to treat tumors,which plays an important role in warming and nourishing,regulating yin and yang,and eliminating cancer toxicity.The combination of war-ming,nourishing and detoxification can promote the return of the phase fire and make the human body's generation and transformation active,providing a new treatment idea for TCM diagnosis and treatment of tumors with mainly cold poison or mixed cold and heat.
10.Construction of p97 mutant of Mesomycoplasma hyopneumoniae based on the homologous recombination system
Yanna WEI ; Jiying WANG ; Huan XIE ; Zhiqiang LI ; Z.A.Ishag HASSAN ; Xing XIE ; Bin XU ; Qiyan XIONG ; Zhixin FENG ; Guoqing SHAO ; Yanfei YU
Chinese Journal of Veterinary Science 2025;45(3):473-481
The aim of this study is to establish an gene editing method of Mesomycoplasma hyo-pneumoniae(Mhp)based on the homologous recombination principle.The restriction enzyme di-gestion and ligation method combined with gene synthesis were used to construct a shuttle plasmid to achieve replication in both Mhp and Escherichia coli(E.coli).The pGEM?-T vector was used as the skeleton.The oriC sequence of Mhp which can achieve the replication of the plasmid in Mhp was inserted into the vector.Sequences of the Spiroplasma promoter and puromycin resistance gene were then inserted into the above constructed plasmid to screen recombinant clones.The up-stream and downstream homologous arms of p97 were constructed to initiate homologous recombination.The recA gene of E.coli is inserted to improve the efficiency of homologous recom-bination.The obtained shuttle plasmid was then delivered into Mhp by electro-transformation or chemical transformation.A shuttle plasmid,pGEM?-Mhp-oriC-p 97,which can replicate in both Mhp and E.coli was constructed.With the transformation of this plasmid,the carried puromycin gene and recA gene can be expressed,the p97 gene can be edited.Finally,the genetically unstable p97 gene mutant was initially obtained.In this study,a tool for Mhp gene editing based on the principle of homologous recombination was established,which laid a foundation for the develop-ment of tools for studying the pathogenesis of Mhp.


Result Analysis
Print
Save
E-mail